AAEV 2026 Annual Meeting
Dates:
November 12, 2026 (4:00 PM) – November 15, 2026 (1:00 PM)
Venue:
The Westin Jersey City Newport
479 Washington Blvd
Jersey City, NJ 07310
Enjoy stunning views of the Hudson River and the Manhattan skyline at The Westin Jersey City Newport.
-Time Square, Manhattan: 35 min
-Statue of Liberty: 15 min
The venue also offers convenient access to all three major airports and regional rail service--
-Newark Liberty International (EWR): 20-30 min
-LaGuardia (LGA): 45-60 min
-John F. Kennedy (JFK): 45-60 min
-Penn Station: 30 min
-- making travel easy for both domestic and international attendees.
AAEV 2026 Co-Chairs
Opening plenary lecture speaker:
Dr. David Lyden
Weill Cornell Medical College
Dr. Lyden completed his M.D. at Brown University, Ph.D. at the University of Vermont, Residency at Duke University, postdoctoral fellowship at Memorial Sloan Kettering Cancer Ceneter; currently, he is the Stavros S. Niarchos Professor of Pediatrics and Cell and Developmental Biology at Weill Cornell Medicine.
Dr. Lyden defined the concept of the "pre-metastatic niche" (PMN), where tumor-secreted factors recruit bone marrow-derived progenitor cells to distant organ sites to provide a platform for metastasis. Dr. Lyden’s work underscores the systemic nature of cancer. As such, Dr. Lyden demonstrated that tumor-derived extracellular vesicle (EV)-mediated crosstalk initiates the PMN and coordinates metastatic progression. He identified key proteins and nucleic acids, specifically double stranded DNA, in EVs and demonstrated their systemic role in thrombosis, fatty liver metabolic dysfunction, and immune dysregulation. He has defined tumor EV integrins in organotropic metastasis, answering in part Stephen Paget’s “seed and soil” hypothesis on organ-specific metastasis. Moreover, he identified a new particle named exomere, which packages distinct proteins, including metabolic enzymes, lipids, and glycans. He has identified novel EV biomarkers for cancer diagnosis and prognosis in patients with cancer.
Dr. Lyden is an elected Member of the Association of American Physicians (2021) and an elected Fellow of the American Association for the Advancement of Science (2022). Dr. Lyden is the recipient of the 2024 Princess Lilian Award for excellence in research and mentoring by the Belgium Royal Family, the 2024 Paget-Ewing Award, the highest award by the Metastasis Research Society, the 2026 AACR Princess Takamatsu Memorial Lectureship Award for his innovative research highlighting multi-national collaboration, and the National Institutes of Health R35 Outstanding Investigator Award, that supports his efforts to explore the systemic effects of metastatic cancer.
Keynote speaker:
Dr. Hailing Jin
University of California, Riverside
Dr. Hailing Jin’s research focuses on the roles of RNAs, epigenetic regulation, and antimicrobial peptides in plant–microbe interactions, with the goal of developing innovative and environmentally sustainable strategies for crop protection against fungal and bacterial pathogens. Her laboratory discovered that RNAs, including small RNAs, mRNAs and long non-coding RNAs, can traffic bidirectionally between plants and their pathogens to regulate gene expression or cellular processes across organismal boundaries. Subsequently revealed that EVs are key vehicles mediating this cross-kingdom RNA communication. More recently, her group discovered EV-mediated RNA trafficking between bacteria and fungi, further expanding this biological paradigm. Cross-kingdom/cross-species RNA communication has since been observed across all kingdoms of life, fundamentally changing our understanding of inter-species or inter-organismal communication. Dr. Jin's laboratory also demonstrated that many fungal pathogens can efficiently take up environmental RNAs and vesicles, providing the mechanistic foundation for the development of spray-induced gene silencing (SIGS) technologies for sustainable crop disease control. In addition, her group has identified several novel classes of plant-derived antimicrobial peptides with broad-spectrum activities that can be harnessed as environmentally friendly biocontrol agents.
Dr. Hailing Jin is a Distinguished Professor and the Cy Mouradick Endowed Chair in the Department of Microbiology & Plant Pathology at the University of California, Riverside, USA. She is an elected Member of US National Academy of Sciences (NAS, 2025), Member of the National Academy of Inventors (NAI, 2022), an elected Fellow of the American Association for the Advancement of Science (AAAS, 2015), the American Academy of Microbiology (AAM, 2020), the American Phytopathological Society (APS, 2024), the American Association of Extracellular Vesicles (2025) and a CIFAR Fellow of the Canadian Institute for Advanced Research (2019). Dr. Jin has published 123 peer-reviewed papers and is recognized as a Clarivate highly cited researcher with more than 24K citations to her work.
Keynote speaker:
Michel Sadelain, MD, PhD
Columbia University
Michel Sadelain is the founding director of the Columbia Institute for Cell Engineering and Therapy at Columbia University, where he is Herbert and Florence Irving Professor of Medicine. He previously founded and directed the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center, where he held the Stephen and Barbara Friedman Chair. He received his M.D. from the University of Paris, his Ph.D. from the University of Alberta, and trained as a post-doctoral fellow at the Whitehead Institute at MIT.
Sadelain has made numerous key contributions to the emergence and success of CD19 chimeric antigen receptor (CAR) therapy. His research contributed to all its facets from concept to implementation, including T cell engineering technologies, the design of CARs, the identification of CD19 as an effective CAR target, T cell manufacturing processes, and the clinical translation of CD19 CAR therapy for the treatment of acute lymphoblastic leukemia.
Sadelain is the recipient of the Coley Award (Cancer Research Institute), Passano Award (Johns Hopkins), Pasteur-Weizmann/Servier International Prize, French Academy of Sciences Medal, Gabbay Award (Brandeis University), INSERM International Prize, Léopold Griffuel Award, ASGCT Outstanding Achievement Award, Breakthrough Prize, Gairdner International Award, Warren Alpert Prize (Harvard), VinFuture, Meyenburg Award and King Faisal Prize.
Early Bird Registration (Deadline: 09/15/2026)
(Additional 20% off for AAEV members)
-
Trainee: $350 (after 09/15: $500)
-
Professional: $600 (after 09/15: $800)
-
Corporate: $1200 (after 09/15: $1400)
Registration link: https://www.aaev.org/aaev2026-registration
Abstract Submission (Deadline: 09/15/2026)
Submitted abstracts will be considered for oral or poster presentations. We are also pleased to introduce a poster award this year. Further details will be announced in September.
Abstract submission: https://www.aaev.org/abstract2026
Hotel Reservation
(Cut-Off Date: 10/19/2026)
We have very limited hotel rooms with our contracted rate $289+tax (regular price $420 + tax). Attendees must make their reservations no later than October 19, 2026 (the “Cut-Off Date”).
Reserve Rooms: https://book.passkey.com/e/51219188
Become AAEV 2026 Sponsors?
Corporate sponsorships include one 6ft table, two chairs, power, advertisement in meeting materials, and announcement on the aaev.org website. Electricity and technical equipment will be provided by the meeting venue during the event.
